VVUS: Summary for VIVUS, Inc. - Yahoo! Canada Finance - Share Prices, Charts, News and more

MORE ON VVUS

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

VIVUS, Inc. (NGM:VVUS) Delayed quote data

Last Trade:	8.46 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	8.46
Open:	N/A
Bid:	8.02 x 200
Ask:	9.94 x 300
1y Target Est:	12.33

Day's Range:	N/A - N/A
52wk Range:	2.72 - 12.88
Volume:	0
Avg Vol (3m):	3,469,400
Market Cap:	681.44M
P/E (ttm):	N/A
EPS (ttm):	-0.68
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add VVUS to Portfolio

Download Data

HEADLINES

•	Lightning Round OT: Patriot Coal, Boeing and More
	at CNBC (Thu, Feb 4)

•	Ahead of the Bell: Arena Pharma upgraded
	AP (Thu, Feb 4)

•	VIVUS to Present at the BIO CEO and Investor Conference
	PRNewswire (Thu, Feb 4)

•	Orexigen shares rise on Jefferies analyst view
	AP (Tue, Feb 2)

•	Lightning Round OT: China Automotive Systems, Vivus and More
	at CNBC (Fri, Jan 29)

•	[$$] Five Drugs That Could Be Blockbusters
	at Barrons.com (Fri, Jan 29)

•	Sector Snap: FDA nod boosts diabetes drugmakers
	AP (Tue, Jan 26)

•	Investors betting heavily on Vivus obesity drug
	at MarketWatch (Thu, Jan 21)

•	The Skinny On Vivus
	at CNBC (Wed, Jan 20)

•	Drug News: Impotence, Arthritis and Schizophrenia
	at The Wall Street Journal Online (Mon, Jan 11)

•	Biotech Stocks: MAP, Inhibitex, Vivus lead drug stocks north
	at MarketWatch (Mon, Jan 11)

More Headlines for VVUS...

ANALYST

EPS Est (next year) (Dec-09) :	-0.83
EPS Est (in 2 years) (Dec-10) :	-0.71
Avg Rec (current)*:	2.3
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

VIVUS, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for underserved markets in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

VIVUS Inc. (VVUS)